Tacik Pawel, Sanchez-Contreras Monica, Rademakers Rosa, Dickson Dennis W, Wszolek Zbigniew K
Department of Neurology, Mayo Clinic Florida, Jacksonville, Fla., USA.
Neurodegener Dis. 2016;16(1-2):12-21. doi: 10.1159/000440840. Epub 2015 Nov 10.
Tauopathies are a group of neurodegenerative disorders characterized by the pathological accumulation of hyperphosphorylated and insoluble tau protein within neurons and glia. Although most cases are sporadic, hereditary tauopathies have also been reported.
In this article, we review genetic disorders in which tau pathology has been reported and present two novel families with primary tauopathies. Mutations in the microtubule-associated protein tau gene (MAPT) cause a small subset of primary tauopathies. Mutations in 21 other genes and an 18q deletion syndrome have also been reported to be associated with tau pathology reminiscent of Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy, argyrophilic grain disease or Pick's disease. In 8 of the 21 genes, tau pathology was only seen in cases with some 'specific' mutations. In the remaining genes, tau pathology, often in the form of Alzheimer-type neurofibrillary lesions, was a common finding but was 'not mutation specific'. The probands of the two families were diagnosed with progressive supranuclear palsy based on clinicopathological evaluation. Their family histories were relevant for parkinsonism in 3 siblings of family 1 and 1 brother and the father from family 2, but these were not autopsy-confirmed. DNA from the brains of the probands from these families was screened for MAPT and leucine-rich repeat kinase 2 gene mutations, but no mutations were identified.
MAPT mutations are a cause of familial tauopathies, but other genes have also been associated with tau pathology. Novel genes still await discovery.
tau蛋白病是一组神经退行性疾病,其特征是神经元和神经胶质细胞内过度磷酸化和不溶性tau蛋白的病理性积聚。虽然大多数病例是散发性的,但也有遗传性tau蛋白病的报道。
在本文中,我们回顾了已报道有tau病理改变的遗传性疾病,并介绍了两个原发性tau蛋白病的新家族。微管相关蛋白tau基因(MAPT)的突变导致一小部分原发性tau蛋白病。据报道,其他21个基因的突变以及18q缺失综合征也与tau病理改变有关,这些改变类似于阿尔茨海默病、皮质基底节变性、进行性核上性麻痹、嗜银颗粒病或皮克病。在这21个基因中的8个基因中,tau病理改变仅在一些“特定”突变的病例中出现。在其余基因中,tau病理改变通常以阿尔茨海默病型神经原纤维病变的形式出现,是一个常见发现,但“并非突变特异性”。根据临床病理评估,这两个家族的先证者被诊断为进行性核上性麻痹。他们的家族史与家族1的3个兄弟姐妹以及家族2的1个兄弟和父亲的帕金森症有关,但这些均未得到尸检证实。对这些家族先证者大脑的DNA进行了MAPT和富含亮氨酸重复激酶2基因突变筛查,但未发现突变。
MAPT突变是家族性tau蛋白病的一个病因,但其他基因也与tau病理改变有关。仍有待发现新的基因。